Antiviral activity of carbohydrate-binding agents and the role of DC-SIGN in dengue virus infection (Q39876850)

15 September 2017

Antiviral activity of carbohydrate-binding agents and the role of DC-SIGN in dengue virus infection (English)

1 reference

viral entry into host cell

15 September 2017

1 reference

1 reference

1 reference

based on heuristic

inferred from abstract

Dominique Schols

6

0 references

Johan Neyts

object named as

Johan Neyts

series ordinal

5

0 references

Jan Balzarini

series ordinal

4

object named as

Jan Balzarini

1 reference

15 September 2017

2

Suzanne J F Kaptein

1 reference

15 September 2017

Marijke M F Alen

1

1 reference

PubMed ID

19264337

15 September 2017

Tine De Burghgraeve

series ordinal

3

1 reference

PubMed ID

19264337

15 September 2017

language of work or name

English

0 references

publication date

4 March 2009

1 reference

15 September 2017

1 reference

15 September 2017

387

1 reference

15 September 2017

67-75

1 reference

15 September 2017

1

1 reference

Targeting the glycans of glycoproteins: a novel paradigm for antiviral therapy

15 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.043

Microbicide drug candidates to prevent HIV infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.043

Alpha-(1-3)- and alpha-(1-6)-D-mannose-specific plant lectins are markedly inhibitory to human immunodeficiency virus and cytomegalovirus infections in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.043

The mannose-specific plant lectins from Cymbidium hybrid and Epipactis helleborine and the (N-acetylglucosamine)n-specific plant lectin from Urtica dioica are potent and selective inhibitors of human immunodeficiency virus and cytomegalovirus replic

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.043

Mannose-specific plant lectins from the Amaryllidaceae family qualify as efficient microbicides for prevention of human immunodeficiency virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.043

Profile of resistance of human immunodeficiency virus to mannose-specific plant lectins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.043

Carbohydrate-binding Agents Cause Deletions of Highly Conserved Glycosylation Sites in HIV GP120

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.043

Carbohydrate-binding agents efficiently prevent dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin (DC-SIGN)-directed HIV-1 transmission to T lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.043

Dengue Fever in Humanized NOD/SCID Mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.043

Entry of hepatitis C virus and human immunodeficiency virus is selectively inhibited by carbohydrate-binding agents but not by polyanions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.043

Recombinant, live-attenuated tetravalent dengue virus vaccine formulations induce a balanced, broad, and protective neutralizing antibody response against each of the four serotypes in rhesus monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.043

Anti-human immunodeficiency virus effects of dextran sulfate are strain dependent and synergistic or antagonistic when dextran sulfate is given in combination with dideoxynucleosides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.043

Sequence and expression of a membrane-associated C-type lectin that exhibits CD4-independent binding of human immunodeficiency virus envelope glycoprotein gp120

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.043

Structural basis for selective recognition of oligosaccharides by DC-SIGN and DC-SIGNR

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.043

Simian immunodeficiency virus is susceptible to inhibition by carbohydrate-binding agents in a manner similar to that of HIV: implications for further preclinical drug development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.043

DC-SIGN-ICAM-2 interaction mediates dendritic cell trafficking.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.043

DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.043

Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.043

Identification of Distinct Antigenic Determinants on Dengue-2 Virus Using Monoclonal Antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.043

Structural basis for distinct ligand-binding and targeting properties of the receptors DC-SIGN and DC-SIGNR.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.043

Human Cytomegalovirus Binding to DC-SIGN Is Required for Dendritic Cell Infection and Target Cell trans-Infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.043

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.043

Mutational analysis of a neutralization epitope on the dengue type 2 virus (DEN2) envelope protein: monoclonal antibody resistant DEN2/DEN4 chimeras exhibit reduced mouse neurovirulence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.043

Sequence analysis of cloned dengue virus type 2 genome (New Guinea-C strain).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.043

Monocytes, but not T or B cells, are the principal target cells for dengue virus (DV) infection among human peripheral blood mononuclear cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.043

Expression of DC-SIGN and DC-SIGNR on Human Sinusoidal Endothelium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.043

Dendritic cell-specific intercellular adhesion molecule 3-grabbing non-integrin (DC-SIGN)-mediated enhancement of dengue virus infection is independent of DC-SIGN internalization signals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.043

Dengue: an arthropod-borne disease of global importance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.043

The mannose receptor mediates dengue virus infection of macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.043

A novel mechanism of carbohydrate recognition by the C-type lectins DC-SIGN and DC-SIGNR. Subunit organization and binding to multivalent ligands

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.043

Essential Role of Dengue Virus Envelope Protein N Glycosylation at Asparagine-67 during Viral Propagation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.043

Dendritic-cell-specific ICAM3-grabbing non-integrin is essential for the productive infection of human dendritic cells by mosquito-cell-derived dengue viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.043

DC-SIGN interactions with human immunodeficiency virus type 1 and 2 and simian immunodeficiency virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.043

Cryo-EM reconstruction of dengue virus in complex with the carbohydrate recognition domain of DC-SIGN.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.043

Carbohydrate-binding agents (CBAs) inhibit HIV-1 infection in human primary monocyte-derived macrophages (MDMs) and efficiently prevent MDM-directed viral capture and subsequent transmission to CD4+ T lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.043

A Dengue Fever Viremia Model in Mice Shows Reduction in Viral Replication and Suppression of the Inflammatory Response after Treatment with Antiviral Drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.043

DC-SIGN (CD209) mediates dengue virus infection of human dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.043

Sugar-binding proteins potently inhibit dendritic cell human immunodeficiency virus type 1 (HIV-1) infection and dendritic-cell-directed HIV-1 transfer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.043

Isolation and characterization of a lectin with exclusive specificity towards mannose from snowdrop (Galanthus nivalis ) bulbs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.043

DC-SIGN: escape mechanism for pathogens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.043

Comparison of dengue infection in human mononuclear leukocytes with mosquito C6/36 and mammalian Vero cells using flow cytometry to detect virus antigen.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.043

Human skin Langerhans cells are targets of dengue virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.043

Functional evaluation of DC-SIGN monoclonal antibodies reveals DC-SIGN interactions with ICAM-3 do not promote human immunodeficiency virus type 1 transmission

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.043

Mutation of Asp(171) and Asp(262) of the chemokine receptor CXCR4 impairs its coreceptor function for human immunodeficiency virus-1 entry and abrogates the antagonistic activity of AMD3100.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.043

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VIROL.2009.01.043

1 reference

15 September 2017

1 reference

PubMed ID

19264337